1st in 50 years: Nod for new Tuberculosis drug
Bedaquiline is in use in US and EU against multi-drug-resistant strains With cases of Multi-Drug Resistant-Tuberculosis (MDR-TB) and extensively drug resistant TB (XDR TB) threatening the country, Bedaquiline
Related Content
- Guidance for the surveillance of drug resistance in tuberculosis: Sixth edition
- No time to wait: Securing the future from drug-resistant infections
- No time to wait: securing the future from drug-resistant infections
- India to get 10,000 free doses of costly TB wonder drug
- Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape
- Pharmacists failing to notify TB cases to be penalised